Lars J.S. Knutsen, Ph.D., President, Requis Pharma, held high-level R&D posts in Glaxo (UK), Novo Nordisk (DK), Vernalis & Ionix Pharma (UK) as Director of Chemistry. Appointed 1st Distinguished Scientist at Cephalon (US), most recently VP, Medicinal Chemistry at NMD Pharma (DK). Lars has inventive involvement in 6 biotech start-ups, holds 65 patents & 46 scientific publications, Adjunct Prof. at Drexel University College of Medicine (2009 - 19).

Marie Johnston, CPA, gained her MBA in 2010, and has senior-level finance experience in a variety of industries, including clinical trials data group TTC, divested to IMS Health. Marie's refined business and strategic skills can be attributed to her hands-on experience and also to her Executive MBA from Keller Business School with focus on International Business. Marie oversees Requis's Operations, including HR and has full oversight of Accounts.

Mark A. Pimley R.Ph. is VP, Pharmaceutics at Requis Pharma, is an experienced Pharmacist, who owned “The Compounding Pharmacist” in West Chester, PA. Mark has provided formulation expertise to several start-up companies and brings a remarkable range of new product ideas to Requis as well as in-depth knowledge about the real world unmet medical needs of patients.

Laurel joined Requis Pharmaceuticals from a Director position at IMS Health. Her previous roles included CEO of Sickweather, COO of Sage Analytica, as well as 11 years in senior sales and operational roles at SDI Health. Prior to SDI, Laurel was Director, Product Commercialization at AstraZeneca in Wayne, PA. Her degree in advanced biochemistry is from the University of Saskatchewan